ExploreInterventionextranodal non-Hodgkin lymphoma diagnosis and treatment
Intervention

extranodal non-Hodgkin lymphoma diagnosis and treatment

Also known as: Prior extranodal non-Hodgkin lymphoma diagnosis and treatment (possibly including pelvic field radiation before pregnancy)
3 findings 1 paper 4 related entities View in graph →

Related entities

conditions
outcomes
populations
studys

Findings (27)

None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6
None
decline

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Size: RR=2.3 CI: 95% CI: 1.5, 3.6

Papers (1)